Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

Hydroxamate-based histone deacetylase inhibitors (Hb-HDACIs), such as vorinostat, belinostat and panobinostat, have been previously shown to have a wide range of activity in hematologic malignancies such as cutaneous T-cell lymphoma and multiple myeloma. Recent data show that they synergize with a v...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Grassadonia, Antonino, Cioffi, Pasquale, Simiele, Felice, Iezzi, Laura, Zilli, Marinella, Natoli, Clara
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2013
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795372/
https://ncbi.nlm.nih.gov/pubmed/24202327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers5030919
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items